Literature DB >> 26658377

Reduced Expression of HLA-DR on Monocytes During Severe Respiratory Syncytial Virus Infections.

Inge M L Ahout1, Jop Jans, Lilid Haroutiounian, Elles R Simonetti, Christa van der Gaast-de Jongh, Dimitri A Diavatopoulos, Marien I de Jonge, Ronald de Groot, Gerben Ferwerda.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) is a common cause of bronchiolitis in infants with a wide spectrum of disease severity. Besides environmental and genetic factors, it is thought that the innate immune system plays a pivotal role. The aim of this study was to investigate the expression of immune receptors on monocytes and the in vitro responsiveness from infants with severe RSV infections.
METHODS: Peripheral blood mononuclear cells (PBMCs) from infants with RSV infections were isolated. Classical, intermediate and nonclassical monocytes were immunophenotyped for the expression of CD14, CD16, human leukocyte antigen (HLA)-ABC and HLA-DR. PBMCs were stimulated with lipopolysaccharide to determine the secretion of tumor necrosis factor and interleukin (IL)-10 with enzyme-linked immunosorbent assay.
RESULTS: During RSV infection, intermediate monocytes are increased in the peripheral blood, whereas classical and nonclassical monocytes are reduced. The expression of CD14 and HLA-ABC is increased on monocytes, whereas the expression of HLA-DR is suppressed. Low HLA-DR expression is correlated with increased disease severity. PBMCs from infants with severe RSV infections show an impaired IL-10 response in vitro.
CONCLUSIONS: Phenotyping subpopulations of monocytes combined with in vitro responsiveness reveals significant differences between nonsevere and severe RSV infections. Reduced HLA-DR expression and impaired IL-10 production in vitro during severe RSV infections indicate that an imbalanced innate immune response may play an important role in disease severity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26658377     DOI: 10.1097/INF.0000000000001007

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

Review 1.  Infant Immune Response to Respiratory Viral Infections.

Authors:  Santtu Heinonen; Rosa Rodriguez-Fernandez; Alejandro Diaz; Silvia Oliva Rodriguez-Pastor; Octavio Ramilo; Asuncion Mejias
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-15       Impact factor: 3.479

2.  Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection.

Authors:  Benedetta Peruzzi; Sara Bencini; Manuela Capone; Alessio Mazzoni; Laura Maggi; Lorenzo Salvati; Anna Vanni; Chiara Orazzini; Carlo Nozzoli; Alessandro Morettini; Loredana Poggesi; Filippo Pieralli; Adriano Peris; Alessandro Bartoloni; Alessandro Maria Vannucchi; Francesco Liotta; Roberto Caporale; Lorenzo Cosmi; Francesco Annunziato
Journal:  Immunology       Date:  2020-10-06       Impact factor: 7.397

3.  Direct and Intestinal Epithelial Cell-Mediated Effects of TLR8 Triggering on Human Dendritic Cells, CD14+CD16+ Monocytes and γδ T Lymphocytes.

Authors:  Costanza Angelini; Barbara Varano; Patrizia Puddu; Maurizio Fiori; Antonella Baldassarre; Andrea Masotti; Sandra Gessani; Lucia Conti
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

Review 4.  Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus.

Authors:  Karen Bohmwald; Janyra A Espinoza; Raúl A Pulgar; Evelyn L Jara; Alexis M Kalergis
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

Review 5.  Host Components Contributing to Respiratory Syncytial Virus Pathogenesis.

Authors:  Jonatan J Carvajal; Andrea M Avellaneda; Camila Salazar-Ardiles; Jorge E Maya; Alexis M Kalergis; Margarita K Lay
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

Review 6.  Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Lena Glaser; Patricia J Coulter; Michael Shields; Olivier Touzelet; Ultan F Power; Lindsay Broadbent
Journal:  Pathogens       Date:  2019-07-19

7.  The Micro-Immunotherapy Medicine 2LEID Exhibits an Immunostimulant Effect by Boosting Both Innate and Adaptive Immune Responses.

Authors:  Camille Jacques; Mathias Chatelais; Karim Fekir; Louis Fauconnier; Manon Mellier; Dieudonnée Togbe; Ilaria Floris
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

Review 8.  Mucosal Immune Responses to Respiratory Syncytial Virus.

Authors:  Megan V C Barnes; Peter J M Openshaw; Ryan S Thwaites
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

9.  Siglec-1 inhibits RSV-induced interferon gamma production by adult T cells in contrast to newborn T cells.

Authors:  Jop Jans; Wendy W J Unger; Marloes Vissers; Inge M L Ahout; Inge Schreurs; Arthur Wickenhagen; Ronald de Groot; Marien I de Jonge; Gerben Ferwerda
Journal:  Eur J Immunol       Date:  2018-01-18       Impact factor: 5.532

10.  Restoration of Peripheral Intermediate and Classical Monocytes Expressing HLA-DR in Patients With Lung Adenocarcinoma After Platinum-Based Chemotherapy.

Authors:  Selma Rivas-Fuentes; Anjarath Higuera Iglesias; Ana García Trejo; Daniel Yair Chavarría Castro; Norma Inclán Figueroa; Teresa Aguirre Pérez; Renata Báez Saldaña; Patricia Gorocica Rosete
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.